Beijing Vitalstar Biotechnology Co.,Ltd.  is a high-tech company established in 2000, specializing in the research and development of genetically modified animal models and providing related products and technical services, in order to promote the research and development and industrialization of disease model animals in China under the advocacy of the National 863 Program.

Co-sponsored Bill&Melinda Gates Foundation's new humanized animal model project.

The highly immunodeficient rat model F344RG was developed

NPG is exported to Korea and Japan

The advent of NGG-B2M;

Establishment of the second generation humanized immune model

NPG sales to Taiwan

Launched new products of NGG-HIL2 and NGG-GM3 mice

Npg-hil3, hCSF2 and other new generation models have been launched.

The second generation of human liver model Hu-URG® was established

F344RG rats exported to Japan;

Beijing Vitonda facility was approved for ABBL-2 qualification;

Beijing Vitonda became a member of the New Drug Liver Disease Alliance;

Launched a new product DK-NPG mice

In February, VS (Suzhou) Biotechnology Co., Ltd. was established;

In January, VS (Gu 'an) Biotechnology Co., Ltd. obtained the laboratory animal production license;

In June, Vitonda (Suzhou) Biotechnology Co., Ltd. obtained the laboratory animal production license and the laboratory animal use license;

In September, Suzhou Taicang experimental facility was officially opened;

Beijing VS has become the governing unit of Beijing Society of Experimental Zoology and Beijing Association of Experimental Animal Industry.

Animal strains exported to Singapore

Expanded use of Beijing facilities;

Co-elected as the standing director unit of Beijing Medical Doctor Association